Ramy A. Mahmoud M.D., M.P.H.
Net Worth

Last updated:

What is Ramy A. Mahmoud M.D., M.P.H. net worth?

The estimated net worth of Dr. Ramy A. Mahmoud M.D., M.P.H. is at least $17,055,677 as of 17 Dec 2024. He owns shares worth $11,495,837 as insider, has earned $1,872,090 from insider trading and has received compensation worth at least $3,687,750 in OptiNose, Inc..

What is the salary of Ramy A. Mahmoud M.D., M.P.H.?

Dr. Ramy A. Mahmoud M.D., M.P.H. salary is $737,550 per year as Pres & Chief Operating Officer in OptiNose, Inc..

How old is Ramy A. Mahmoud M.D., M.P.H.?

Dr. Ramy A. Mahmoud M.D., M.P.H. is 60 years old, born in 1965.

What stocks does Ramy A. Mahmoud M.D., M.P.H. currently own?

As insider, Dr. Ramy A. Mahmoud M.D., M.P.H. owns shares in one company:

Company Title Shares Price per share Total value
OptiNose, Inc. (OPTN) Pres & Chief Operating Officer 1,197,483 $9.6 $11,495,837

What does OptiNose, Inc. do?

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

OPTN logo
OPTN
OptiNose, Inc.
$9.6

Ramy A. Mahmoud M.D., M.P.H. insider trading

OptiNose, Inc.

Dr. Ramy A. Mahmoud M.D., M.P.H. has made 39 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 4,614 units of OPTN stock worth $2,030 on 17 Dec 2024.

The largest trade he's ever made was exercising 366,133 units of OPTN stock on 23 Nov 2020. As of 17 Dec 2024 he still owns at least 1,197,483 units of OPTN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 4,614 $0.44 $2,030
Sale
Common Stock 4,881 $0.87 $4,246
Sale
Common Stock 111,426 $1.14 $127,026
Sale
Common Stock 18,987 $1.19 $22,595
Sale
Common Stock 19,198 $1.88 $36,092
Sale
Common Stock 52,875 $1.31 $69,266
Sale
Common Stock 11,114 $1.15 $12,781
Sale
Common Stock 11,083 $1.37 $15,184
Sale
Common Stock 3,543 $1.15 $4,074
Sale
Common Stock 11,040 $1.79 $19,762
Sale
Common Stock 8,148 N/A N/A
Sale
Common Stock 7,507 N/A N/A
Sale
Common Stock 2,945 $3.56 $10,484
Sale
Common Stock 23,663 $3.55 $84,004
Sale
Common Stock 28,074 $3.49 $97,978
Sale
Common Stock 8,219 $2.11 $17,342
Sale
Common Stock 916 $1.64 $1,502
Option
Common Stock 12,499 $2.79 $34,860
Sale
Restricted Stock Units 11,588 N/A N/A
Sale
Common Stock 911 $2.79 $2,541
Option
Common Stock 12,499 $2.79 $34,860
Option
Restricted Stock Units 39,754 N/A N/A
Option
Restricted Stock Units 39,754 N/A N/A
Sale
Common Stock 39,754 N/A N/A
Sale
Common Stock 909 $3.73 $3,391
Sale
Common Stock 3,636 $3.92 $14,253
Option
Stock Option (Right to Buy) 85,016 $1.63 $138,576
Option
Common Stock 113,358 $1.63 $184,774
Option
Common Stock 113,358 $1.63 $184,774
Sale
Common Stock 31,271 $4.03 $126,147
Sale
Common Stock 31,271 $4.03 $126,147
Option
Stock Option (Right to Buy) 27,912 $1.63 $45,497
Option
Common Stock 27,912 $1.63 $45,497
Option
Stock Option (Right to Buy) 27,912 $1.63 $45,497
Option
Stock Option (Right to Buy) 27,912 $0.82 $22,748
Option
Common Stock 27,912 $1.63 $45,497
Option
Common Stock 27,912 $0.82 $22,748
Sale
Common Stock 7,816 $4.32 $33,734
Sale
Common Stock 7,816 $4.32 $33,734
Sale
Common Stock 7,816 $4.32 $33,734
Sale
Common Stock 7,816 $2.16 $16,867
Option
Stock Option (Right to Buy) 99,924 $1.22 $122,207
Option
Stock Option (Right to Buy) 99,924 $1.63 $162,876
Option
Common Stock 99,924 $1.63 $162,876
Sale
Common Stock 28,252 $4.39 $123,885
Sale
Common Stock 28,252 $2.19 $61,957
Option
Stock Option (Right to Buy) 99,924 $1.63 $162,876
Option
Common Stock 99,924 $0.82 $81,438
Option
Common Stock 99,924 $1.63 $162,876
Sale
Common Stock 28,252 $4.39 $123,885
Sale
Common Stock 28,252 $4.39 $123,885
Option
Common Stock 366,133 N/A N/A
Sale
Common Stock 109,920 $4.5 $494,640
Sale
Common Stock 109,920 N/A N/A
Option
Stock Option (Right to Buy) 366,133 N/A N/A
Option
Stock Option (Right to Buy) 366,133 $1.63 $596,797
Option
Common Stock 366,133 $1.63 $596,797
Option
Common Stock 5,618 $1.63 $9,157
Option
Common Stock 429 $5.06 $2,172
Sale
Common Stock 1,285 N/A N/A
Option
Stock Option (Right to Buy) 5,618 $1.63 $9,157
Option
Common Stock 6,047 N/A N/A
Option
Stock Option (Right to Buy) 5,618 N/A N/A
Option
Stock Option (Right to Buy) 13,097 N/A N/A
Option
Common Stock 13,097 $1.63 $21,348
Option
Stock Option (Right to Buy) 13,097 $1.63 $21,348
Option
Common Stock 13,097 N/A N/A
Sale
Common Stock 3,972 N/A N/A
Sale
Common Stock 6,700 $4.32 $28,924
Option
Stock Option (Right to Buy) 19,410 N/A N/A
Sale
Common Stock 6,700 N/A N/A
Option
Common Stock 19,410 N/A N/A
Sale
Common Stock 2,313 N/A N/A
Option
Common Stock 6,704 N/A N/A
Option
Common Stock 6,704 $1.63 $10,928
Option
Stock Option (Right to Buy) 6,704 $1.63 $10,928
Option
Stock Option (Right to Buy) 6,704 N/A N/A

OptiNose key executives

OptiNose, Inc. executives and other stock owners filed with the SEC: